(Z)-1,2-Diphenylethene

(Z)-1,2-Diphenylethene

SCHEMBL347707

C(=C\c1ccccc1)\c1ccccc1

nearest known ligand 0.73

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 3/20 0.73
NFE2L2 Q16236 4/20 0.67
CYP19A1 P11511 2/20 0.67
MAOA P21397 2/20 0.67
MEN1 O00255 1/20 0.63
KMT2A Q03164 1/20 0.63
CHAT P28329 2/20 0.60
TRPA1 O75762 3/20 0.58
ALDH1A1 P00352 1/20 0.58
LMNA P02545 1/20 0.58
ALOX5 P09917 1/20 0.58
MAPK1 P28482 1/20 0.58
RELA Q04206 2/20 0.57
CYP11B1 P15538 1/20 0.57
CYP11B2 P19099 1/20 0.57
HDAC3 O15379 1/20 0.55
TNKS O95271 1/20 0.55
HDAC4 P56524 1/20 0.55
HDAC1 Q13547 1/20 0.55
HCAR2 Q8TDS4 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
(Z)-1,2-Diphenylethene SCHEMBL21847984 1.00 MAOB (0.73) MAOBNFE2L2CYP19A1MAOAMEN1
(Z)-1,2-Diphenylethene SCHEMBL9134305 1.00 MAOB (0.73) MAOBNFE2L2CYP19A1MAOAMEN1
(Z)-1,2-Diphenylethene SCHEMBL442 1.00 MAOB (0.73) MAOBNFE2L2CYP19A1MAOAMEN1
(Z)-1,2-Diphenylethene SCHEMBL443 1.00 MAOB (0.73) MAOBNFE2L2CYP19A1MAOAMEN1
(Z)-1,2-Diphenylethene SCHEMBL9134296 1.00 MAOB (0.73) MAOBNFE2L2CYP19A1MAOAMEN1
(Z)-1,2-Diphenylethene SCHEMBL9488270 1.00 MAOB (0.73) MAOBNFE2L2CYP19A1MAOAMEN1
(Z)-1,2-Diphenylethene SCHEMBL9488275 1.00 MAOB (0.73) MAOBNFE2L2CYP19A1MAOAMEN1
(Z)-1,2-Diphenylethene SCHEMBL22712863 1.00 MAOB (0.73) MAOBNFE2L2CYP19A1MAOAMEN1
(Z)-1,2-Diphenylethene SCHEMBL23852642 0.96 MAOB (0.69) MAOBNFE2L2CYP19A1MAOAMEN1
(Z)-1,2-Diphenylethene SCHEMBL22634166 0.96 MAOB (0.69) MAOBNFE2L2CYP19A1MAOAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1668 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260048152-A1 GEMCITABINE INORGANIC-ORGANIC HYBRID NANOPARTICLES KARLSRUHER INSTITUT FUER TECH KOERPERSCHAFT DES OEFFENTLICHEN RECHTS (DE) 2026-02-19 US claimed
US-20250084452-A1 BIOLOGICAL INDICATOR FOR DETERMINING THE EFFICACY OF A STERILIZATION PROCESS AND METHODS OF USE TERRAGENE LLC 2025-03-13 US claimed
WO-2024259294-A2 PROTEOMIMETIC SCAFFOLDS AND USES THEREOF NEW YORK UNIVERSITY (US) 2024-12-19 WO claimed
US-12145951-B2 Inorganic-organic hybrid compounds including organic platinum-containing anions, for use in medicine KARLSRUHER INSTITUT FUR TECHNOLOGIE (DE) 2024-11-19 US claimed
CN-116870877-B Mixed mode chromatographic stationary phase with multistage pore structure and preparation method and application thereof 河南工业大学 2024-06-25 CN claimed
CN-117959191-A Use of agonist compounds in skin care compositions 广州銮滢化妆品有限公司 2024-05-03 CN claimed
CN-117845235-A Preparation method of cis-stilbene compound 深圳市环保科技集团股份有限公司 2024-04-09 CN claimed
CN-117050454-A Impact-resistant polypropylene composite material and preparation method thereof 合肥乾润钢塑有限公司 2023-11-14 CN claimed
CN-116904143-A Room-temperature-cured temperature-resistant PMMA adhesive and manufacturing method thereof 浙江华帅特新材料科技有限公司 2023-10-20 CN claimed
CN-116870877-A Mixed mode chromatographic stationary phase with multistage pore structure and preparation method and application thereof 河南工业大学 2023-10-13 CN claimed
US-5219928-A TRANSPARENT LIQUID ABSORBENT MATERIALS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1993-06-15 US claimed
US-5216178-A Contacting with alkaline earth metal and lower alkanol HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1993-06-01 US claimed
EP-0521904-A1 MODIFICATION OF POLYMER SURFACES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1993-01-13 EP claimed
EP-0482837-A1 Transparent liquid absorbent materials MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1992-04-29 EP claimed
EP-0460994-A1 Method and apparatus to make evident one or more shocks received by a substrate HUTCHINSON S.A. une SociÀ©té Anonyme dotée d'un Conseil de Surveillance et d'un Directoire (FR) 1991-12-11 EP claimed
WO-1991014730-A1 MODIFICATION OF POLYMER SURFACES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1991-10-03 WO claimed
US-5051312-A Contacting a polymer with a modifier while irradiating with actinic radiation to form a pattern E. I. DU PONT DE NEMOURS AND COMPANY (US) 1991-09-24 US claimed
WO-1991010634-A1 NITROGEN-CONTAINING AROMATIC HETEROCYCLIC LIGAND-METAL COMPLEXES AND THEIR USE FOR THE ACTIVATION OF HYDROGEN PEROXIDE AND DIOXYGEN IN THE REACTION OF ORGANIC COMPOUNDS TEXAS A&M UNIVERSITY SYSTEM (US) 1991-07-25 WO claimed
EP-0250254-B1 CIS & TRANS STILBENES AND THEIR COMPOSITION FOR THE TREATMENT OF HYPERTENSION McNeilab, Inc. (US) 1991-06-19 EP claimed
US-3965206-A Production of stilbene and styrene MONSANTO COMPANY (US) 1976-06-22 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260048152-A1 GEMCITABINE INORGANIC-ORGANIC HYBRID NANOPARTICLES GOT1, RNMT, GNAO1 MAOB 4443/4885NFE2L2 1853/4885CYP19A1 4754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.